LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Normalized Growth Rate Inhibition Value | Standard Error of the Mean for Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | GSK1059615 | 10 | uM | LJP5 | 0.1879 | 0.0125 | -0.4141 | 0.0859 |
| SK-BR-3 | GSK1059615 | 10 | uM | LJP6 | 0.1952 | 0.0192 | -0.4282 | 0.0705 |
| SK-BR-3 | Brivanib | 0.04 | uM | LJP5 | 0.8820 | 0.0501 | 0.8107 | 0.0801 |
| SK-BR-3 | Brivanib | 0.12 | uM | LJP5 | 0.8722 | 0.0607 | 0.7980 | 0.0956 |
| SK-BR-3 | Brivanib | 0.37 | uM | LJP5 | 0.8794 | 0.0565 | 0.8069 | 0.0892 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 0.9122 | 0.0431 | 0.8610 | 0.0659 |
| SK-BR-3 | Brivanib | 3.33 | uM | LJP5 | 0.9042 | 0.0396 | 0.8503 | 0.0625 |
| SK-BR-3 | Brivanib | 10 | uM | LJP5 | 0.8859 | 0.0356 | 0.8218 | 0.0593 |
| SK-BR-3 | CHIR-99021 | 0.04 | uM | LJP6 | 0.8335 | 0.0331 | 0.7313 | 0.0670 |
| SK-BR-3 | CHIR-99021 | 0.12 | uM | LJP6 | 0.8338 | 0.0511 | 0.7249 | 0.0964 |
| SK-BR-3 | CHIR-99021 | 0.37 | uM | LJP6 | 0.8723 | 0.0511 | 0.7856 | 0.0904 |
| SK-BR-3 | CHIR-99021 | 1.11 | uM | LJP6 | 0.8500 | 0.0508 | 0.7493 | 0.0957 |
| SK-BR-3 | CHIR-99021 | 3.33 | uM | LJP6 | 0.8531 | 0.0542 | 0.7533 | 0.0984 |
| SK-BR-3 | CHIR-99021 | 10 | uM | LJP6 | 0.6752 | 0.0487 | 0.4654 | 0.1176 |
| SK-BR-3 | Linifanib | 0.04 | uM | LJP6 | 1.0787 | 0.0218 | 1.1136 | 0.0268 |
| SK-BR-3 | Linifanib | 0.12 | uM | LJP6 | 1.0535 | 0.0144 | 1.0764 | 0.0147 |
| SK-BR-3 | Linifanib | 0.37 | uM | LJP6 | 1.0797 | 0.0249 | 1.1129 | 0.0248 |
| SK-BR-3 | Linifanib | 1.11 | uM | LJP6 | 1.0662 | 0.0301 | 1.0973 | 0.0451 |
| SK-BR-3 | Linifanib | 3.33 | uM | LJP6 | 1.0640 | 0.0310 | 1.0910 | 0.0452 |
| SK-BR-3 | Linifanib | 10 | uM | LJP6 | 0.5316 | 0.0195 | 0.2319 | 0.0417 |
| SK-BR-3 | PIK-93 | 0.04 | uM | LJP5 | 1.0599 | 0.0110 | 1.0881 | 0.0176 |
| SK-BR-3 | PIK-93 | 0.12 | uM | LJP5 | 1.0610 | 0.0159 | 1.0922 | 0.0260 |
| SK-BR-3 | PIK-93 | 0.37 | uM | LJP5 | 1.0020 | 0.0398 | 1.0120 | 0.0545 |
| SK-BR-3 | PIK-93 | 1.11 | uM | LJP5 | 0.9366 | 0.0562 | 0.9163 | 0.0719 |
| SK-BR-3 | PIK-93 | 3.33 | uM | LJP5 | 0.7353 | 0.0160 | 0.5970 | 0.0216 |